Medical News

RSS

Sunesis Pharmaceuticals enrolls 113 patients in voreloxin REVEAL-1 trial

Sunesis Pharmaceuticals, Inc. today reported that it has completed enrollment in the REVEAL-1 (Response Evaluation of VorEloxin in AmL) trial, a Phase 2 dose regimen optimization trial of single agent voreloxin in newly diagnosed elderly acute myeloid leukemia (AML) patients who are unlikely to benefit from standard induction chemotherapy. A total of 113 patients were enrolled and dosed according to one of three dosing schedules.

30 Oct 2009

CCBR-SYNARC to expand its Electronic Data Capture capabilities for use in imaging clinical trials

CCBR-SYNARC, the world's leading provider of medical image analysis, biochemical marker, and clinical research center services to the pharmaceutical and biotechnology industries, announced the expansion of its Electronic Data Capture ("EDC") capabilities for use in imaging clinical trials.

30 Oct 2009

New social networking site for breast cancer survivors

Breast cancer activists, survivors and supporters now have their very own online Web community to share unique experiences and insights around breast cancer. Launching this week, the new social networking site “myKomen” centers on individual and shared experiences with a disease that will afflict 200,000 women and men this year alone.

30 Oct 2009

Trusted Process thought leaders at INC Research named winners at the 2009 Clinical Research Excellence Awards

INC Research®, Inc., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, is pleased to announce that Trusted Process® thought leaders at INC Research were named winners at the 2009 Clinical Research Excellence Awards in London on October 20.

30 Oct 2009

Idenix Pharmaceuticals reports phase I study results of IDX184 for treating HCV

Idenix Pharmaceuticals, Inc.a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced presentations of data on IDX184, a once-daily novel liver-targeted nucleotide prodrug of 2'-methyl guanosine (2'MeG) for the treatment of HCV, at the annual meeting of the American Association for the Study of Liver Diseases (AASLD) currently being held in Boston, Massachusetts.

30 Oct 2009

Valeant Pharmaceuticals to acquire prescription and cosmetic products rights from Polish

Valeant Pharmaceuticals International (NYSE: VRX) today announced that it has agreed to acquire the rights to several prescription and cosmetic dermatology products from a privately-held, Polish specialty pharmaceutical company.

30 Oct 2009

Left side grafting has lower risk to donors; small graft size not the only cause of 'small-for-size graft syndrome'

A recent study by doctors at Shinshu University, School of Medicine, in Japan determined that left side grafting has lower risk to donors compared to grafts taken from the right lobe, and it appears to be the procedure of choice for adult-to-adult living donor liver transplantation (LDLT).

30 Oct 2009

Walnut Village, a full-service retirement community, officially opens its door to Anaheim residents

Walnut Village, a new, full-service retirement community in the heart of Anaheim, Calif., officially opened to its first residents this month.

30 Oct 2009

Stockholders of SCM Microsystems approve increase of the amount of common shares

SCM Microsystems, Inc., a leading provider of solutions for secure access, secure identity and secure exchange, announced today that its stockholders have approved an increase of the amount of common shares authorized during yesterday's annual meeting of stockholders.

30 Oct 2009

Michigan residents sue State over denied access to dental healthcare

In a move aimed at forcing the State of Michigan and the Legislature to protect the rights of Michigan's most vulnerable population, including the developmentally disabled and those with minimal financial resources, a lawsuit was filed in federal court against the Granholm Administration. A class of more than 400,000 at-risk Michigan residents is suing the State for failing to uphold its legal obligations with regard to funding certain dental care services under the federal Medicaid program.

30 Oct 2009

PMSI Holdings to purchase rights under the patent portfolio held by Ronald A. Katz Technology Licensing

Ronald A. Katz Technology Licensing, L.P. announced today that PMSI Holdings Corporation, one of the world's largest pharmaceutical services companies serving the United States with headquarters in Tampa, FL, has entered into an agreement to purchase rights under the patent portfolio held by Ronald A. Katz Technology Licensing, L.P. and licensed through its affiliate, A2D, L.P.

30 Oct 2009

Merge Healthcare and MEDRAD announce an expansion of their EU Distribution Agreement for CADstream

Merge Healthcare, a health IT solutions leader, and MEDRAD, a leading provider of medical devices and services for diagnostic imaging, today announced an expansion of their European Union Distribution Agreement for CADstream, a dedicated CAD system for MRI.

30 Oct 2009

Repros Therapeutics signs settlement agreement with major creditors

Repros Therapeutics today announced that the Company has entered into a settlement agreement with its major creditors for the large majority of the debt incurred associated with the recently suspended Proellex® clinical program.

30 Oct 2009

Updated results from Oncolytics Biotech's Phase II study of REOLYSIN presented at CTOS meeting

Oncolytics Biotech Inc. announced that a poster presentation covering updated results of a Phase II study of REOLYSIN(R) administered intravenously to patients with sarcomas metastatic to the lung will be presented at the 15th Annual Connective Tissue Oncology Society (CTOS) Meeting being held in Miami Beach, Florida on November 6th, 2009.

30 Oct 2009

Eisai reports global Phase III study results of eribulin mesylate

Eisai Inc. today announced preliminary results from a recently completed Phase III study with eribulin mesylate (E7389), discovered and developed by the company, in patients with locally advanced or metastatic breast cancer.

30 Oct 2009

Mollen Immunization Clinics sets US record for administering 14,000 vaccinations in a single event

With just 36 hours notice from the Maricopa County Department of Public Health, Mollen Immunization Clinics administered over 14,000 vaccinations to high-risk groups throughout the county, one of the nation's largest with a population of four million residents.

30 Oct 2009

First Choice Health Services to be included in the top-performing home health agencies in the US

First Choice Health Services, Inc. today announced that it has been named to the 2009 HomeCare Elite , a compilation of the top-performing home health agencies in the United States.

30 Oct 2009

Third-quarter fiscal 2009 results announced by HMS Holdings

HMS Holdings Corp. today announced its financial results for the third quarter of 2009.

30 Oct 2009

Patients on immunosuppressant medication can receive H1N1 vaccine in the form of shots

The Centers for Disease Control and Prevention (CDC) have classified all children, 6-months to 24-years, one of the high risk groups for contracting the H1N1 (swine) flu, and recommend this population receive the H1N1 vaccine for immunity against the disease.

30 Oct 2009

Siemens Hearing Instruments introduces new hearing solutions at the ADA 2009 Convention

Siemens Hearing Instruments, Inc., (www.usa.siemens.com/hearing) one of the largest manufacturers of hearing instruments in the world, today announced several new product models and enhancements at SPLASH: The Academy of Doctors of Audiology's (ADA) 2009 Convention held October 29-31, 2009, in Clearwater, Florida.

30 Oct 2009

Medical News

Sunesis Pharmaceuticals enrolls 113 patients in voreloxin REVEAL-1 trial

CCBR-SYNARC to expand its Electronic Data Capture capabilities for use in imaging clinical trials

New social networking site for breast cancer survivors

Trusted Process thought leaders at INC Research named winners at the 2009 Clinical Research Excellence Awards

Idenix Pharmaceuticals reports phase I study results of IDX184 for treating HCV

Valeant Pharmaceuticals to acquire prescription and cosmetic products rights from Polish

Left side grafting has lower risk to donors; small graft size not the only cause of 'small-for-size graft syndrome'

Walnut Village, a full-service retirement community, officially opens its door to Anaheim residents

Stockholders of SCM Microsystems approve increase of the amount of common shares

Michigan residents sue State over denied access to dental healthcare

PMSI Holdings to purchase rights under the patent portfolio held by Ronald A. Katz Technology Licensing

Merge Healthcare and MEDRAD announce an expansion of their EU Distribution Agreement for CADstream

Repros Therapeutics signs settlement agreement with major creditors

Updated results from Oncolytics Biotech's Phase II study of REOLYSIN presented at CTOS meeting

Eisai reports global Phase III study results of eribulin mesylate

Mollen Immunization Clinics sets US record for administering 14,000 vaccinations in a single event

First Choice Health Services to be included in the top-performing home health agencies in the US

Third-quarter fiscal 2009 results announced by HMS Holdings

Patients on immunosuppressant medication can receive H1N1 vaccine in the form of shots

Siemens Hearing Instruments introduces new hearing solutions at the ADA 2009 Convention

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News